Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pemix is an Argentinian pharmaceutical company that specializes in the development, manufacturing, and distribution of high-complexity pharmaceutical products. The company focuses on therapeutic areas such as oncology, hematology, HIV, and rare diseases, providing a portfolio of specialty drugs and generic alternatives. Pemix operates primarily in the Latin American market, aiming to improve access to critical treatments through its regional distribution network and manufacturing capabilities. Its business model combines the commercialization of its own products with the representation of international pharmaceutical brands in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pemix.